Ligand Pharmaceuticals
LGND
#2818
Rank
NZ$10.69 B
Marketcap
NZ$534.76
Share price
-2.62%
Change (1 day)
50.19%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2026 (TTM): NZ$4.48

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$4.71. In 2025 the company made an earnings per share (EPS) of NZ$11.47 an increase over its 2024 EPS that were of NZ-$0.09100.

EPS history for Ligand Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.48-60.91%
2025NZ$11.47-12700%
2024NZ-$0.09100-101.73%
2023NZ$5.26-245.96%
2022NZ-$3.60-157.23%
2021NZ$6.30-2571.43%
2020NZ-$0.25-100.46%
2019NZ$55.71353.48%
2018NZ$12.291025%
2017NZ$1.09-700%
2016NZ-$0.18-100.87%
2015NZ$21.041859.32%
2014NZ$1.075.36%
2013NZ$1.028.0704505322479E+18%
2012NZ$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-72.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.22 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.63 571.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.57-154.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-61.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.23 74.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.24 11.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ-$0.66-113.90%๐Ÿ‡บ๐Ÿ‡ธ USA